Effect of parenteral oestrogen on the coagulation system in patients with prostatic carcinoma

British Journal of Urology
P HenrikssonK Carlström

Abstract

Patients with prostatic carcinoma on oral oestrogen therapy have an altered coagulation system and suffer cardiovascular side effects. Oestrogens--especially oral oestrogens--are potent inducers of liver synthesised proteins, including coagulation factors. We have assessed the effect of non-oral oestrogen on the coagulation system in patients with prostatic carcinoma. Twelve patients were given monthly intramuscular injections of 320 mg polyoestradiol phosphate (PEP). No additional oestrogens were given. No change was found in any of the coagulation factors, including factor VII, with the exception of a significant decrease in antithrombin III. No patient, including 38 patients treated with PEP, had any cardiovascular complications after a mean follow-up period of 12.9 +/- 0.7 months; 76% of the patients responded to treatment. Parenteral administration of oestrogen caused a less marked change in the coagulation system than oral administration and should be the treatment of choice for prostatic carcinoma.

References

Jan 1, 1989·Medical Oncology and Tumor Pharmacotherapy·P HenrikssonO Vesterqvist
Aug 16, 1986·British Medical Journal·P Henriksson, O Edhag
Sep 1, 1980·The Journal of Clinical Endocrinology and Metabolism·F L GeolaH L Judd
Sep 15, 1983·Thrombosis Research·D B RylattA J Webber
May 1, 1963·Clinica Chimica Acta; International Journal of Clinical Chemistry·C VERMYLENM VERSTRAETE
Jan 1, 1951·Acta Haematologica·F KOLLERF DUCKERT

❮ Previous
Next ❯

Citations

Aug 1, 1995·Calcified Tissue International·S ErikssonK Carlström
Jan 1, 1991·International Journal of Technology Assessment in Health Care·P Henriksson, R Stege
Oct 5, 2006·Nature Clinical Practice. Oncology·Jeremy OckrimPaul Abel
Jan 24, 2007·Clinical Genitourinary Cancer·Jennifer L LycetteTomasz M Beer
Oct 1, 1995·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·P Ekman
Dec 1, 1995·The Journal of Urology·R L Cox, E D Crawford
Jul 2, 2017·Endocrine-related Cancer·Nicholas RussellMathis Grossmann
Apr 11, 2003·The Journal of Urology·J L OckrimP D Abel
May 1, 1997·Memórias do Instituto Oswaldo Cruz·R Lainson
Oct 12, 2005·Journal of Morphology·Alan FeducciaJ Richard Hinchliffe
Nov 2, 2005·Scandinavian Journal of Urology and Nephrology·Arto MikkolaUNKNOWN Finnprostate group
Dec 23, 2009·Memórias do Instituto Oswaldo Cruz·Elizabeth Ferreira Rangel, Ralph Lainson
Nov 22, 2013·Scandinavian Journal of Urology·Rafal TuroGerald N Collins
Dec 17, 2014·PLoS Neglected Tropical Diseases·Renata Cássia-PiresAndré Luiz R Roque

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.